English
中文简体
中文繁体
Company
Overview
Management
SAB
Board of Directors
Partnering
Technology
Bispecific
Mix-mAb
Biologics Manufacturing
Publications
Pipeline
Overview
KN035
KN046
KN026
KN019
Investors
Information Disclosure
Corporate Governance
Stock Information
IR Contacts
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
Company
Overview
Management
SAB
Board of Directors
Partnering
Technology
Bispecific
Mix-mAb
Biologics Manufacturing
Publications
Pipeline
Overview
KN035
KN046
KN026
KN019
Investors
Information Disclosure
Corporate Governance
Stock Information
IR Contacts
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
English
中文简体
中文繁体
Investors
Information Disclosure
Listing Documents
Announcements & Circulars
Corporate Governance
Stock Information
IR Contacts
Email Subscription
Announcements & Circulars
The announcement begins in December 2019
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2020
2020-04-03
CONNECTED TRANSACTION ANNOUNCEMENT - TECHNOLOGY DEVELOPMENT AGREEMENT WITH SUZHOU ALPHAMAB ON PROCESS OPTIMIZATION AND TRANSFER OF KN019, KN026 AND KN035 AND TECHNOLOGY DEVELOPMENT AGREEMENT WITH SUZHOU ALPHAMAB ON PROCESS SCALE-UP RESEARCH OF KN052
2020-03-31
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2019
2020-03-31
INSIDE INFORMATION ANNOUNCEMENT - COLLABORATIVE AGREEMENT WITH SIMCERE PHARMACEUTICAL AND 3D MEDICINES FOR KN035 AND SUPPLEMENTAL AGREEMENTS TO THE KN035 CO-DEVELOPMENT AGREEMENT
2020-03-30
VOLUNTARY ANNOUNCEMENT - COLLABORATION WITH PFIZER ON KN026 IN COMBINATION WITH IBRANCE(PALBOCICLIB) IN HER2+ BREAST CANCER
2020-03-27
DATE OF BOARD MEETING
2020-03-18
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2020
2020-03-04
VOLUNTARY ANNOUNCEMENT - FOUR IND APPLICATIONS ACCEPTED BY NMPA CDE FOR TWO ANTI-TUMOR BISEPECIFIC ANTIBODIES IN PIPELINE
2020-02-20
VOLUNTARY ANNOUNCEMENT - JIANGSU ALPHAMAB PASSED ON-SITE INSPECTION OF EU QUALIFIED PERSON
2020-02-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020
2020-02-05
Next Day Disclosure Return
2020-01-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019
2020-01-06
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
2020-01-05
INSIDE INFORMATION ANNOUNCEMENT – COLLABORATIVE PARTNERSHIP AGREEMENT WITH TRACON AND 3DMED
2019-12-20
VOLUNTARY ANNOUNCEMENT - COMPLETION OF CONSTRUCTION OF THE PHASE I MANUFACTURING FACILITIES
2019-12-18
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE II CLINICAL TRIAL OF KN019 FOR RHEUMATOID ARTHRITIS TREATMENT IN CHINA
2019-12-16
Terms of Reference of the Strategy Committee
2019-12-11
Terms of Reference of the Remuneration Committee
2019-12-11
Terms of Reference of the Audit Committee
2019-12-11
Terms of Reference of the Nomination Committee
2019-12-11
